Huo et al. reported that BI 2536, a small molecule drug, effectively inhibited the proliferation of ovarian cancer cells by triggering both apoptosis and pyroptosis via the caspase-3/GSDME pathway [137]. Here, GSDME is linked to ovarian carcinoma.